Leloup Arthur J A, Van Hove Cor E, Heykers Annick, Schrijvers Dorien M, De Meyer Guido R Y, Fransen Paul
Laboratory of Physiopharmacology, Department of Pharmaceutical Sciences, University of Antwerp Antwerp, Belgium.
Laboratory of Pharmacology, Faculty of Medicine and Health Sciences, University of Antwerp Antwerp, Belgium.
Front Physiol. 2015 Dec 15;6:375. doi: 10.3389/fphys.2015.00375. eCollection 2015.
In the last decades, the search for mechanisms underlying progressive arterial stiffening and for interventions to avoid or reverse this process has gained much attention. In general, arterial stiffening displays regional variation and is, for example, during aging more prominent in elastic than in muscular arteries. We hypothesize that besides passive also active regulators of arterial compliance [i.e., endothelial and vascular smooth muscle cell (VSMC) function] differ between these arteries. Hence, it is conceivable that these vessel types will display different time frames of stiffening. To investigate this hypothesis segments of muscular arteries such as femoral and mesenteric arteries and elastic arteries such as the aorta and carotid artery were isolated from female C57Bl6 mice (5-6 months of age, n = 8). Both microscopy and passive stretching of the segments in a myograph confirmed that passive mechanical properties (elastin, collagen) of elastic and muscular arteries were significantly different. Endothelial function, more specifically basal nitric oxide (NO) efficacy, and VSMC function, more specifically L-type voltage-gated Ca(2+) channel (VGCC)-mediated contractions, were determined by α1-adrenoceptor stimulation with phenylephrine (PE) and by gradual depolarization with elevated extracellular K(+) in the absence and presence of eNOS inhibition with L-NAME. PE-mediated isometric contractions significantly increased after inhibition of NO release with L-NAME in elastic, but not in muscular vessel segments. This high basal eNOS activity in elastic vessels was also responsible for shifts of K(+) concentration-contraction curves to higher external K(+). VGCC-mediated contractions were similarly affected by depolarization with elevated K(+) in muscular artery segments or in elastic artery segments in the absence of basal NO. However, K(+)-induced contractions were inhibited by the VGCC blocker diltiazem with significantly higher sensitivity in the muscular arteries, suggestive of different populations of VGCC isoforms in both vessel types. The results from the present study demonstrate that, besides passive arterial wall components, also active functional components contribute to the heterogeneity of arterial compliance along the vascular tree. This crucially facilitates the search for (patho) physiological mechanisms and potential therapeutic targets to treat or reverse large artery stiffening as occurring in aging-induced arterial stiffening.
在过去几十年中,对动脉进行性硬化的潜在机制以及避免或逆转这一过程的干预措施的研究备受关注。一般来说,动脉僵硬存在区域差异,例如在衰老过程中,弹性动脉比肌性动脉更为明显。我们推测,除了被动因素外,动脉顺应性的主动调节因子(即内皮细胞和血管平滑肌细胞(VSMC)功能)在这些动脉之间也存在差异。因此,可以想象这些血管类型在僵硬的时间框架上会有所不同。为了验证这一假设,从雌性C57Bl6小鼠(5 - 6月龄,n = 8)中分离出股动脉和肠系膜动脉等肌性动脉段以及主动脉和颈动脉等弹性动脉段。显微镜检查和在肌动描记器中对动脉段的被动拉伸均证实,弹性动脉和肌性动脉的被动力学特性(弹性蛋白、胶原蛋白)存在显著差异。通过用去氧肾上腺素(PE)刺激α1 - 肾上腺素能受体以及在存在和不存在L - NAME抑制内皮型一氧化氮合酶(eNOS)的情况下用升高的细胞外K⁺进行逐步去极化,来测定内皮功能,更具体地说是基础一氧化氮(NO)功效,以及VSMC功能,更具体地说是L型电压门控Ca²⁺通道(VGCC)介导的收缩。在用L - NAME抑制NO释放后,弹性血管段中PE介导的等长收缩显著增加,而肌性血管段则没有。弹性血管中这种较高的基础eNOS活性也导致K⁺浓度 - 收缩曲线向更高的外部K⁺水平移动。在不存在基础NO的情况下,肌性动脉段或弹性动脉段中升高的K⁺去极化对VGCC介导的收缩有类似影响。然而,K⁺诱导的收缩在肌性动脉中被VGCC阻滞剂地尔硫䓬抑制,其敏感性显著更高,这表明两种血管类型中存在不同的VGCC亚型群体。本研究结果表明,除了动脉壁的被动成分外,主动功能成分也导致了沿血管树的动脉顺应性的异质性。这对于寻找治疗或逆转衰老诱导的动脉僵硬中出现的大动脉僵硬的(病理)生理机制和潜在治疗靶点至关重要。